News

Scripps Research, IAVI, Fred Hutch, VRC and other collaborators publish study data in Science, helping validate novel vaccination strategy.

In a Scripps Research study, a nanoparticle treatment ‘cured’ mice that had a genetic arthritis condition.

A Scripps Research team showed how drugs can reduce alcohol preference in animal models of post-traumatic stress disorder.

Thirteen scientists were named to Clarivate’s Highly Cited Researchers list: a methodology for identifying the most influential researchers from around the world.  

A Scripps Research team developed a new tool that can predict how Parkinson’s disease patients will fare over the course of a year based on their genetics, brain scans and physical examinations. 

Finding uncovers a key property needed for CELMoD drugs, a type of protein degrader, to work effectively.

The five-year grant will support the development and distribution of innovative computational tools for advanced drug discovery.

Scripps Research findings unexpectedly show that heroin, not its metabolites, is the best therapeutic target.

The $3.8 million award will expand the institute’s research programs aimed at identifying therapeutics for various RNA viruses.

Discovery points the way toward an effective HCV vaccine.

A Scripps Research team measured how levels of various proteins in brain cells change in response to brain activity.

Scripps Research and Calibr scientists collaborate to uncover potential therapeutic avenues for metabolic diseases.

Work will include fast analyses of virus transmission in the San Diego area and across the U.S.- Mexico border.

Sharpless awarded his second Nobel Prize in Chemistry–one of only two chemists to ever receive such an honor.

Calibr, the drug development arm of Scripps Research, and other collaborators find microglia play a critical role in SMA disease progression.

Two studies from Scripps Research and collaborators combine bioinformatics and other techniques to develop new vaccine candidates against HIV.

Scripps Research team showed that a variation of an already FDA-approved therapeutic for neurological disease can block COVID-19 infection in animals.

Scripps Research scientists pinpoint an unusual culprit in cancer: a family of genes that respond to temperature changes in the body.

New analysis finds that climate change and other factors could soon make deadly Lassa fever a much bigger public health problem in Africa

New data from Scripps Research shows how sensors can provide real-time COVID-19 tracking and forecasting

Calibr has announced encouraging preliminary data from the first nine subjects in a first-in-human Phase 1 clinical trial studying the first switchable CAR-T cell product (CLBR001 + SWI019) for patients with B cell malignancies.

Scientists identify WASH protein complex as a gatekeeper of neutrophil-driven inflammation

Park’s expertise in high-resolution imaging will enable a detailed look at bacterial pathogenesis.

Newly discovered sensory neurons send messages from fat tissue to the brain and could eventually be co-opted to treat obesity or metabolic disease.